Latest filing published 06 Jul 2026 for Werewolf Therapeutics, Inc., €6,308.
Insider track record
MPM Oncology Innovations Fund, L.P.: trading record in brief
This profile gathers the share dealings of MPM Oncology Innovations Fund, L.P. in Werewolf Therapeutics, Inc. Between 29 June 2026 and 6 July 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 6 July 2026 came the latest disclosure, a transaction for €6,308 in Werewolf Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to MPM Oncology Innovations Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,194 shares@ US$0.34040.015% mcap49.0% of flowCommonSEC144:0001628280-26-047367
- 23,248 shares@ US$0.3230.016% mcap51.0% of flowCommonSEC144:0001628280-26-046087
2 of 2 declarations
